Clinical Trial: Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Patients With Migraine

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Patients With Migraine.

Brief Summary: Approximately 9% of men and 18% of women suffer from migraine headaches. Almost all migraine sufferers report light sensitivity during a headache. Some people with migraine report that light can trigger their migraines and some people with migraine are light sensitive all of the time. The investigators have recently determined that certain colors of light are more likely to trigger migraines than other colors. In this study the investigators want to know if people who wear glasses that block these colors of light will have fewer migraine headaches.

Detailed Summary:
Sponsor: Bradley Katz

Current Primary Outcome: HIT-6 [ Time Frame: 10 weeks ]

Primary outcome measure is improvement in HIT-6 while wearing therapeutic lenses compared to baseline. The HIT-6 is the Headache Impact Test, a trademarked and copyrighted test (2001 QualityMetric, Inc. and GlaxoSmithKline Group of Companies)


Original Primary Outcome: Same as current

Current Secondary Outcome: Headache frequency and severity [ Time Frame: 10 weeks ]

Secondary outcome is reduction in headache frequency and severity as assessed by headache diaries.


Original Secondary Outcome: Same as current

Information By: University of Utah

Dates:
Date Received: April 7, 2013
Date Started: March 2013
Date Completion:
Last Updated: March 30, 2016
Last Verified: March 2016